
Megoal Trio 20mg/10mg/12.5mg Tablet
Marketer
Ridhima Biocare
Salt Composition
Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Megoal Trio 20mg/10mg/12.5mg Tablet
Tri-Med HP 20mg/10mg/12.5mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, significantly reducing the risk of stroke and myocardial infarction. Administer Tri-Med HP with food, following your doctor's prescribed dosage and schedule for optimal results. Consistent daily use is crucial, even during symptom-free periods, as hypertension often lacks noticeable symptoms. Discontinuing treatment may heighten the risk of cardiovascular events. This medication includes a diuretic, increasing urinary frequency; therefore, avoid ingestion within four hours of bedtime. Common side effects include edema (ankle swelling), headache, dizziness, vertigo, fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your physician immediately. Maintain adequate hydration to mitigate potential side effects like dry mouth and muscle weakness. Prior to initiating treatment, disclose any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical counsel. Inform your doctor about all concurrent medications, especially those for hypertension or cardiovascular issues. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is essential to ensure treatment efficacy and safety.
Uses of Megoal Trio 20mg/10mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Megoal Trio 20mg/10mg/12.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Megoal Trio 20mg/10mg/12.5mg tablets with food.
Common Side effects of Megoal Trio 20mg/10mg/12.5mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
- Vertigo
How to use Megoal Trio 20mg/10mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Megoal Trio 20mg/10mg/12.5mg Tablet whole; do not break, crush, or chew it. Administer this medication with food.
How Megoal Trio 20mg/10mg/12.5mg Tablet works:
Megoal Trio tablets (20mg/10mg/12.5mg) combine olmesartan medoxomil, cilnidipine, and chlorthalidone to manage hypertension. Olmesartan medoxomil (an ARB) and cilnidipine (a CCB) act synergistically to vasodilate, thus reducing blood pressure. Chlorthalidone, a diuretic, lowers blood pressure by promoting fluid excretion and, in the long term, contributing to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Megoal Trio 20mg/10mg/12.5mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Megoal Trio 20mg/10mg/12.5mg tablets is contraindicated during pregnancy due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Megoal Trio 20mg/10mg/12.5mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Megoal Trio 20mg/10mg/12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Megoal Trio 20mg/10mg/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised; the medication is generally unsuitable for such individuals.
LiverCAUTION
Patients with liver impairment should use Megoal Trio 20mg/10mg/12.5mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Megoal Trio 20mg/10mg/12.5mg Tablet :
Should you forget a Megoal Trio 20mg/10mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Megoal Trio 20mg/10mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
